Sen. Wyden ques­tions Pfiz­er over tax rate as part of on­go­ing in­ves­ti­ga­tion

Sen­ate Fi­nance Chair Ron Wyden (D-OR) is press­ing Pfiz­er over its tax prac­tices as part of his in­ves­ti­ga­tion in­to how large phar­ma com­pa­nies use sub­sidiaries …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER